Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors
Open Access
- 23 July 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 7 (1), 133
- https://doi.org/10.1186/1471-2407-7-133
Abstract
Aberrant promoter hypermethylation of cancer-associated genes occurs frequently during carcinogenesis and may serve as a cancer biomarker. In this study we aimed at defining a quantitative gene promoter methylation panel that might identify the most prevalent types of renal cell tumors.Keywords
This publication has 29 references indexed in Scilit:
- Classification of Renal Neoplasms Based on Molecular SignaturesJournal of Urology, 2006
- Identification of Novel Target Genes by an Epigenetic Reactivation Screen of Renal CancerCancer Research, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Multigene Methylation Analysis for Detection and Staging of Prostate CancerClinical Cancer Research, 2005
- Novel approaches in the therapy of metastatic renal cell carcinomaWorld Journal of Urology, 2005
- Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation AnalysisClinical Cancer Research, 2004
- Quantitative Detection of Promoter Hypermethylation of Multiple Genes in the Tumor, Urine, and Serum DNA of Patients with Renal CancerCancer Research, 2004
- Promoter Hypermethylation Profile of Kidney CancerClinical Cancer Research, 2004
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- Searching for the hereditary causes of renal-cell carcinomaNature Reviews Cancer, 2004